FAKTOR-FAKTOR YANG MEMPENGARUHI INSIDENSI KUSTA PASCA KEMOPROFILAKSIS RIFAMPICIN DOSIS TUNGGAL DI DESA AERGALE WILAYAH KERJA PUSKESMAS ONGKAW
DOI:
https://doi.org/10.31004/prepotif.v9i1.43075Keywords:
Kusta, kemoprofilaksis, rifampicin dosis tunggal, faktor risiko, pencegahanAbstract
Kusta masih menjadi masalah kesehatan masyarakat di Indonesia, termasuk di Desa Aergale, Minahasa Selatan. Pemberian kemoprofilaksis rifampicin dosis tunggal merupakan salah satu upaya pencegahan, namun efektivitasnya dipengaruhi oleh berbagai faktor. Penelitian ini bertujuan untuk menganalisis faktor-faktor yang mempengaruhi insidensi kusta pasca kemoprofilaksis di wilayah tersebut. Metode: Penelitian ini menggunakan desain case-control dengan sampel 90 responden yang terdiri dari 30 kasus dan 60 kontrol. Data dikumpulkan melalui wawancara terstruktur dan pengukuran antropometri. Analisis dilakukan menggunakan uji chi-square dan regresi logistik. Analisis statistik menunjukkan bahwa tingkat pendidikan (p=0,000), status vaksinasi BCG (p=0,006), kepatuhan minum obat kemoprofilaksis (p=0,000), status ekonomi (p=0,000), kebersihan diri (p=0,000), dan riwayat kontak erat (p=0,000) berhubungan signifikan dengan insidensi kusta. Namun, status gizi tidak memiliki hubungan yang signifikan (p=0,349). Insidensi kusta pasca kemoprofilaksis masih dipengaruhi oleh faktor sosial, ekonomi, dan perilaku individu. Oleh karena itu, strategi pencegahan harus mencakup edukasi kesehatan, peningkatan akses ekonomi, serta penguatan monitoring dan evaluasi program kemoprofilaksis.References
Kemenkes. (2016). Pedoman Nasional Program pengendalian penyakit Kusta. In Jakarta: Kemenkes RI (p. 192).
Kemenkes RI. (2020). Pedoman Nasional Pelayanan Kedokteran Tatalaksana Kusta. Kementerian Kesehatan RI, 106. https://kbbi.kemdikbud.go.id/entri/Tata Laksana
Kementerian Kesehatan Republik Indonesia. (2022). Annual Report Leprosy Control Program 2022. 9–38.
WHO. (2024). Guidelines for the Diagnosis, Treatment and Prevention of Leprosy. 1–87.
World Health Organization. (2023). Menyibak Harapan: Dukungan WHO dalam Pemberian Profilaksis Pasca-pajanan untuk Eliminasi Kusta di Sulawesi. 2025.
Bahari, & Manoppo, M. W. (2024). EKSPLORASI FAKTOR SOSIAL BUDAYA TERHADAP PREVALENSI KUSTA DI PAPUA : STUDI KUALITATIF. Klabat Journal of Nursing, 6(2).
Bandjar, F. K., Asmin, E., & Sulfiana, F. C. N. (2024). PENGETAHUAN DAN SIKAP MASYRAKAT TERHADAP PENYAKIT KUSTA DI DAERAH ENDEMIS KUSTA, KOTA TUAL, MALUKU: KAJIAN BERBASIS KOMUNITAS. Molucca Medica, 17(November), 6–11.
Campbell, P. O., Bauro, T., Rimon, E., Timeon, E., Bland, C., Ioteba, N., Douglas, N. M., Cunanan, A., & Chambers, S. T. (2024). Single-Dose Rifampicin Leprosy Chemoprophylaxis for Household Contacts in Kiribati: An Audit of a Combined Retrospective and Prospective Approach. Tropical Medicine and Infectious Disease, 9(3). https://doi.org/10.3390/tropicalmed9030058
Cordeiro, W. de M., Rocha, A. M. da, Silva, T. L., Bandeira, M. A. M., & Arrais, P. S. D. (2024). Lessons learned from chemoprophylaxis programmes for neglected diseases and diseases of poverty in Latin America: a systematic review. Caderno Pedagógico, 21(7), e5810. https://doi.org/10.54033/cadpedv21n7-153
Etikan, I. (2016). Comparison of Convenience Sampling and Purposive Sampling. American Journal of Theoretical and Applied Statistics, 5(1), 1. https://doi.org/10.11648/j.ajtas.20160501.11
Kaliki, M. F., & Tunny, R. (2024). Hubungan Personal Hygiene dengan Kejadian Kusta di Wilayah Kerja Puskesmas Nania Kota Ambon. Jurnal Rumpun Kesehatan Umum, 14(3), 75–82. https://journal2.stikeskendal.ac.id/index.php/PSKM/article/view/1979/1260
Lamonge, A. S., Grace B. Polii, A. D. P. M., & Pontoh, N. I. (2024). Stigma Masyarakat dan Upaya Edukasi Berbasis Keluarga Terkait Penyakit Kusta. JUIPERDO JURNAL ILMIAH PERAWAT MANADO, 1–12.
Li, X., Ma, Y., Li, G., Jin, G., Xu, L., Li, Y., Wei, P., & Zhang, L. (2024). Leprosy: treatment, prevention, immune response and gene function. Frontiers in Immunology, 15(February), 1–18. https://doi.org/10.3389/fimmu.2024.1298749
Novita, B. D. (2020). CHEMOPROPHYLAXIS VERSUS IMMUNOPROPHYLAXIS IN TUBERCULOSIS AND LEPROSY INFECTION. Jurnal Widya Medika, 6(1), 65–71. http://journal.wima.ac.id/index.php/JWM/article/view/2504
Richardus, J. H., Tiwari, A., Barth-Jaeggi, T., Arif, M. A., Banstola, N. L., Baskota, R., Blaney, D., Blok, D. J., Bonenberger, M., Budiawan, T., Cavaliero, A., Gani, Z., Greter, H., Ignotti, E., Kamara, D. V., Kasang, C., Manglani, P. R., Mieras, L., Njako, B. F., … Steinmann, P. (2021). Leprosy post-exposure prophylaxis with single-dose rifampicin (LPEP): an international feasibility programme. The Lancet Global Health, 9(1), e81–e90. https://doi.org/10.1016/S2214-109X(20)30396-X
Rusyda, A. L. (2024). a Scoping Review of Nutrition and Diet-Related Factors in Combating Leprosy Disease. Journal of Nutrition College, 13(2), 163–176. https://doi.org/10.14710/jnc.v13i2.40341
Susanto, T., Bahtiar, S., Rokhmah, D., Deviantony, F., Puspitaningtyas, Z., & Rif’ah, E. N. (2022). The Experiences of Leprosy Clients Attending Self-Care Groups During Community-Based Rehabilitation for Fulfilling Their Health Needs. Indian Journal of Leprosy, 94(1), 13–22.
Wang, H. (2024). Evidence of leprosy post exposure prophylaxis in highly endemic regions. The Lancet Global Health, 12(6), e905–e906. https://doi.org/10.1016/S2214-109X(24)00122-0
Willis, M., Fastenau, A., Penna, S., & Klabbers, G. (2024). Interventions to reduce leprosy related stigma: A systematic review. PLOS Global Public Health, 4(8 August), 1–13. https://doi.org/10.1371/journal.pgph.0003440
Zuhdan, E., Kabulrachman, K., & Hadisaputro, S. (2019). Faktor-Faktor yang Mempengaruhi Kejadian Kusta Pasca Kemoprofilaksis (Studi pada Kontak Penderita Kusta di Kabupaten Sampang). Jurnal Epidemiologi Kesehatan Komunitas, 2(2), 89. https://doi.org/10.14710/jekk.v2i2.4001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Vianny Dellya Christine Maramis
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
